Highly immunoreactive IgG antibodies directed against a set of twenty human proteins in the sera of patients with amyotrophic lateral sclerosis identified by protein array

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  May, Caroline ^a   Nordhoff, Eckhard ^a   Casjens, Swaantje ^b   Turewicz, Michael ^a   Eisenacher, Martin ^a   Gold, Ralf ^c   Brüning, Thomas ^b   Pesch, Beate ^b   Stephan, Christian ^a   Woitalla, Dirk ^c   Penke, Botond ^d   Janáky, Tamás ^d   Virók, Dezso ^d   Siklós, László ^e   Engelhardt, Jozsef I ^d   Meyer, Helmut E ^a,f  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c ST JOSEF HOSPITAL   (Germany)

^d UNIVERSITY OF SZEGED   (Hungary)

^e INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^f LEIBNIZ INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN ISAS E V   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; ANTIBODY; BIOLOGICAL MARKER; IMMUNOGLOBULIN G;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIGEN BINDING; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN MICROARRAY; ADOLESCENT; ANIMAL; BLOOD; COMPARATIVE STUDY; FOLLOW UP; IMMUNOLOGY; MOTONEURON; MOUSE; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; MALE; MICE; MIDDLE AGED; MOTOR NEURONS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; YOUNG ADULT;

EID: 84896267999     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089596     Document Type: Article

References (62)

1. Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ (2011) Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 7: 616-630.
2. Andersen PM, Al-Chalabi A (2011) Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 7: 603-615.
3. Al-Chalabi A, Hardiman O (2013) The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol 9: 617-628.
4. Bowser R, Turner MR, Shefner J (2011) Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nat Rev Neurol 7: 631-638.
5. Engelhardt JI, Soos J, Obal I, Vigh L, Siklos L (2005) Subcellular localization of IgG from the sera of ALS patients in the nervous system. Acta Neurol Scand 112: 126-133. (Pubitemid 41003373)
6. Pagani MR, Gonzalez LE, Uchitel OD (2011) Autoimmunity in amyotrophic lateral sclerosis: past and present. Neurol Res Int 2011: 497080.
7. Pestronk A, Choksi R (1997) Multifocal motor neuropathy. Serum IgM anti- GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology 49: 1289-1292. (Pubitemid 27495631)
8. Ordonez G, Sotelo J (1989) Antibodies against fetal muscle proteins in serum from patients with amyotrophic lateral sclerosis. Neurology 39: 683-686. (Pubitemid 19126967)
9. Greiner A, Marx A, Muller-Hermelink HK, Schmausser B, Petzold K, et al. (1992) Vascular autoantibodies in amyotrophic lateral sclerosis. Lancet 340: 378-379.
10. Smith RG, Hamilton S, Hofmann F, Schneider T, Nastainczyk W, et al. (1992) Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med 327: 1721-1728.
11. Couratier P, Yi FH, Preud'homme JL, Clavelou P, White A, et al. (1998) Serum autoantibodies to neurofilament proteins in sporadic amyotrophic lateral sclerosis. J Neurol Sci. Netherlands. pp. 137-145.
12. Niebroj-Dobosz I, Dziewulska D, Janik P (2006) Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS). Folia Neuropathol. Poland. pp. 191-196.
13. Yi FH, Lautrette C, Vermot-Desroches C, Bordessoule D, Couratier P, et al. (2000) In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients. J Neuroimmunol. Netherlands. pp. 211-220.
14. Fialova L, Svarcova J, Bartos A, Ridzon P, Malbohan I, et al. (2010) Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis. Eur J Neurol. England. pp. 562-566.
15. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1: 293-299.
16. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, et al. (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169: 13-21. (Pubitemid 29502501)
17. Jiang H, Deng Y, Chen HS, Tao L, Sha Q, et al. (2004) Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes. BMC Bioinformatics 5: 81.
18. Team RDC (2011) R: A Language and Envronment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
19. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
20. Smyth GK (2005) Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York: Springer. pp. 397-420.
21. Sboner A, Karpikov A, Chen G, Smith M, Mattoon D, et al. (2009) Robust-linear-model normalization to reduce technical variability in functional protein microarrays. J Proteome Res 8: 5451-5464.
22. Love B (2007) The Analysis of Protein Arrays. Functional Protein Microarrays in Drug Discovery: CRC Press. pp. 381-402.
23. Turewicz M, May C, Ahrens M, Woitalla D, Gold R, et al. (2013) Improving the default data analysis workflow for large autoimmune biomarker discovery studies with ProtoArrays. Proteomics 13: 2083-2087.
24. Díaz-Uriarte R, Alvarez de Andrés S (2006) Gene selection and classification of microarray data using random forest. BMC Bioinformatics 7: 3.
25. Hastie T, Tibshirani R, Eisen MB, Alizadeh A, Levy R, et al. (2000) 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol 1: RESEARCH0003.
26. Baek S, Tsai CA, Chen JJ (2009) Development of biomarker classifiers from high-dimensional data. Brief Bioinform 10: 537-546.
27. Nagele E, Han M, Demarshall C, Belinka B, Nagele R (2011) Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera. PLoS One 6: e23112.
28. Han M, Nagele E, Demarshall C, Acharya N, Nagele R (2012) Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera. PLoS One 7: e32383.
29. Alexianu ME, Kozovska M, Appel SH (2001) Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57: 1282- 1289.
30. Sta M, Sylva-Steenland RM, Casula M, de Jong JM, Troost D, et al. (2011) Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation. Neurobiol Dis 42: 211-220.
31. Lasiene J, Yamanaka K (2011) Glial cells in amyotrophic lateral sclerosis. Neurol Res Int 2011: 718987.
32. Henkel JS, Engelhardt JI, Siklos L, Simpson EP, Kim SH, et al. (2004) Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55: 221-235. (Pubitemid 38166999)
33. Engelhardt JI, Tajti J, Appel SH (1993) Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol 50: 30-36. (Pubitemid 23019197)
34. Engelhardt JI, Appel SH (1990) IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol 47: 1210-1216. (Pubitemid 20381002)
35. Engelhardt JI, Siklos L, Komuves L, Smith RG, Appel SH (1995) Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse 20: 185-199.
36. Behrens T, Bonberg N, Casjens S, Pesch B, Brüning T (2013) A practical guide to epidemiological practice and standards in the identification and validation of diagnostic markers using a bladder cancer example. Biochim Biophys Acta.
37. Sakane A, Honda K, Sasaki T (2010) Rab13 regulates neurite outgrowth in PC12 cells through its effector protein, JRAB/MICAL-L2. Mol Cell Biol. United States. pp. 1077-1087.
38. Nokes RL, Fields IC, Collins RN, Folsch H (2008) Rab13 regulates membrane trafficking between TGN and recycling endosomes in polarized epithelial cells. J Cell Biol. United States. pp. 845-853.
39. Gonatas NK, Stieber A, Mourelatos Z, Chen Y, Gonatas JO, et al. (1992) Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am J Pathol 140: 731-737.
40. Valdez AC, Cabaniols JP, Brown MJ, Roche PA (1999) Syntaxin 11 is associated with SNAP-23 on late endosomes and the trans-Golgi network. J Cell Sci 112 (Pt 6): 845-854. (Pubitemid 29179317)
41. Kretzschmar S, Volknandt W, Zimmermann H (1996) Colocalization on the same synaptic vesicles of syntaxin and SNAP-25 with synaptic vesicle proteins: a re-evaluation of functional models required? Neurosci Res. Ireland. pp. 141-148.
42. Yasuno K, Bilguvar K, Bijlenga P, Low SK, Krischek B, et al. (2010) Genomewide association study of intracranial aneurysm identifies three new risk loci. Nat Genet 42: 420-425.
43. Maruyama H, Morino H, Ito H, Izumi Y, Kato H, et al. (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature. England. 223-226.
44. Yang Y, Hentati A, Deng HX, Dabbagh O, Sasaki T, et al. (2001) The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet. United States. pp. 160-165.
45. Soo KY, Farg M, Atkin JD (2011) Molecular motor proteins and amyotrophic lateral sclerosis. Int J Mol Sci. Switzerland. pp. 9057-9082.
46. Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, et al. (2003) Mutant dynactin in motor neuron disease. Nat Genet. United States. 455-456.
47. Frodin M, Gammeltoft S (1999) Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol. Ireland. pp. 65-77.
48. Cantero-Recasens G, Fandos C, Rubio-Moscardo F, Valverde MA, Vicente R (2010) The asthma-associated ORMDL3 gene product regulates endoplasmic reticulum-mediated calcium signaling and cellular stress. Hum Mol Genet. England. pp. 111-121.
49. Hjelmqvist L, Tuson M, Marfany G, Herrero E, Balcells S, et al. (2002) ORMDL proteins are a conserved new family of endoplasmic reticulum membrane proteins. Genome Biol 3: RESEARCH0027.
50. Martina JA, Lelouvier B, Puertollano R (2009) The calcium channel mucolipin- 3 is a novel regulator of trafficking along the endosomal pathway. Traffic. Denmark. pp. 1143-1156.
51. Mizuno Y, Takahashi K, Totsune K, Ohneda M, Konno H, et al. (1995) Decrease in cerebellin and corticotropin-releasing hormone in the cerebellum of olivopontocerebellar atrophy and Shy-Drager syndrome. Brain Res. Netherlands. pp. 115-118.
52. Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, et al. (2011) p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol 122: 691-702.
53. Noguchi K, Fukazawa H, Murakami Y, Uehara Y (2002) Nek11, a new member of the NIMA family of kinases, involved in DNA replication and genotoxic stress responses. J Biol Chem. United States. pp. 39655-39665.
54. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER 3rd, Hurov KE, et al. (2007) ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. United States. pp. 1160-1166.
55. Lowe J, Errington DR, Lennox G, Pike I, Spendlove I, et al. (1992) Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystallin. Neuropathol Appl Neurobiol 18: 341-350.
56. Irobi J, Almeida-Souza L, Asselbergh B, De Winter V, Goethals S, et al. (2010) Mutant HSPB8 causes motor neuron-specific neurite degeneration. Hum Mol Genet. England. pp. 3254-3265.
57. Linial M, Levius O (1993) VAT-1 from Torpedo is a membranous homologue of zeta crystallin. FEBS Lett. Netherlands. pp. 91-94.
58. Struyf S, Burdick MD, Proost P, Van Damme J, Strieter RM (2004) Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis. Circ Res. United States. pp. 855-857.
59. Wu D, Yu W, Kishikawa H, Folkerth RD, Iafrate AJ, et al. (2007) Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol 62: 609-617.
60. Rodrigues MC, Hernandez-Ontiveros DG, Louis MK, Willing AE, Borlongan CV, et al. (2012) Neurovascular aspects of amyotrophic lateral sclerosis. Int Rev Neurobiol. United States: 2012 Elsevier Inc. pp. 91-106.
61. Nawa M, Kanekura K, Hashimoto Y, Aiso S, Matsuoka M (2008) A novel Akt/PKB-interacting protein promotes cell adhesion and inhibits familial amyotrophic lateral sclerosis-linked mutant SOD1-induced neuronal death via inhibition of PP2A-mediated dephosphorylation of Akt/PKB. Cell Signal. England. pp. 493-505.
62. Appel SH, Stockton-Appel V, Stewart SS, Kerman RH (1986) Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations. Arch Neurol 43: 234-238. (Pubitemid 16117834)